UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 236

Sortiert nach

Cancer stem cells and signaling pathways in radioresistance

Oncotarget, 2016-03, Vol.7 (10), p.11002-11017

2016

Volltextzugriff (PDF)

Emerging roles of radioresistance in prostate cancer metastasis and radiation therapy

Cancer and metastasis reviews, 2014-09, Vol.33 (2-3), p.469-496

2014

Volltextzugriff (PDF)

Cancer stem cells in prostate cancer chemoresistance

Current cancer drug targets, 2014-01, Vol.14 (3), p.225

2014

Volltextzugriff (PDF)

Proteomics discovery of radioresistant cancer biomarkers for radiotherapy

Cancer letters, 2015-12, Vol.369 (2), p.289-297

2015

Volltextzugriff (PDF)

Anti-MUC1 monoclonal antibody (C595) and docetaxel markedly reduce tumor burden and ascites, and prolong survival in an in vivo ovarian cancer model

PloS one, 2011-09, Vol.6 (9), p.e24405

2011

Volltextzugriff (PDF)

In vitro and in vivo prostate cancer metastasis and chemoresistance can be modulated by expression of either CD44 or CD147

PloS one, 2012-08, Vol.7 (8), p.e40716

2012

Volltextzugriff (PDF)

Proteomic identification of the lactate dehydrogenase A in a radioresistant prostate cancer xenograft mouse model for improving radiotherapy

Oncotarget, 2016-11, Vol.7 (45), p.74269-74285

2016

Volltextzugriff (PDF)

Combination therapy with the histone deacetylase inhibitor LBH589 and radiation is an effective regimen for prostate cancer cells

PloS one, 2013-08, Vol.8 (8), p.e74253-e74253

2013

Volltextzugriff (PDF)

Low dose histone deacetylase inhibitor, LBH589, potentiates anticancer effect of docetaxel in epithelial ovarian cancer via PI3K/Akt pathway in vitro

Cancer letters, 2013-02, Vol.329 (1), p.17-26

2013

Volltextzugriff (PDF)

Monitoring Prostate Tumor Growth in an Orthotopic Mouse Model Using Three-Dimensional Ultrasound Imaging Technique

Translational oncology, 2016-02, Vol.9 (1), p.41-45

2016

Volltextzugriff (PDF)

Targeting PI3K/Akt/mTOR signaling pathway in the treatment of prostate cancer radioresistance

Critical reviews in oncology/hematology, 2015-12, Vol.96 (3), p.507-517

2015

Volltextzugriff (PDF)

Epithelial cell adhesion molecule (EpCAM) is associated with prostate cancer metastasis and chemo/radioresistance via the PI3K/Akt/mTOR signaling pathway

The international journal of biochemistry & cell biology, 2013-12, Vol.45 (12), p.2736-2748

2013

Volltextzugriff (PDF)

TEM study on the microstructure of the Zn-Al-Mg alloy

Materials characterization, 2017-07, Vol.129, p.336-343

2017

Volltextzugriff (PDF)

Identification of protein biomarkers and signaling pathways associated with prostate cancer radioresistance using label-free LC-MS/MS proteomic approach

Scientific reports, 2017-02, Vol.7 (1), p.41834-41834, Article 41834

2017

Volltextzugriff (PDF)

Co-expression of CD147/EMMPRIN with monocarboxylate transporters and multiple drug resistance proteins is associated with epithelial ovarian cancer progression

Clinical & experimental metastasis, 2010-12, Vol.27 (8), p.557-569

2010

Volltextzugriff (PDF)

Applicability of Artificial Recharge of Groundwater in the Yongding River Alluvial Fan in Beijing through Numerical Simulation

Journal of earth science (Wuhan, China), 2014-06, Vol.25 (3), p.575-586

2014

Volltextzugriff (PDF)

Abstract 2001: Identification of lactate dehydrogenase A (LDHA) as a potential therapeutic target for prostate cancer radiotherapy

Cancer research (Chicago, Ill.), 2015-08, Vol.75 (15_Supplement), p.2001-2001

2015

Volltextzugriff (PDF)

Abstract A283: PI3K/Akt/mTOR dual inhibitors have an advantage over single inhibitors in overcoming prostate cancer radioresistance

Molecular cancer therapeutics, 2013-11, Vol.12 (11_Supplement), p.A283-A283

2013

Volltextzugriff (PDF)

CD44 is a biomarker associated with human prostate cancer radiation sensitivity

Clinical & experimental metastasis, 2012, Vol.29 (1), p.1-9

2012

Volltextzugriff (PDF)

Abstract 4005: CD44 isoform variant 6 is associated with prostate cancer progression, metastasis and chemo-/radio-resistance via PI3K/Akt/mTOR and Wnt/β-catenin signaling pathways in vitro

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19_Supplement), p.4005-4005

2014

Volltextzugriff (PDF)

Low dose histone deacetylase inhibitor, LBH589, potentiates anticancer effect of docetaxel in epithelial ovarian cancer via PI3K/Akt pathwayin vitro

Cancer letters, 2013-02, Vol.329 (1), p.17

2013

Volltextzugriff (PDF)

Kvl.3 channel blockade enhances the phagocytic function of RAW264.7 macrophages

中国科学：生命科学英文版, 2015 (9), p.867-875

ZHU Hong YAN Li GU JingLi HAO Wei CAO JiMin

2015

Volltextzugriff (PDF)

Monoclonal antibody targeting MUC1 and increasing sensitivity to docetaxel as a novel strategy in treating human epithelial ovarian cancer

Cancer letters, 2011-01, Vol.300 (2), p.122-133

2011

Volltextzugriff (PDF)

Monitoring Prostate Tumor Growth in an Orthotopic Mouse Model Using Three-Dimensional Ultrasound Imaging Technique12

Translational oncology, 2016-03, Vol.9 (1), p.41-45

2016

Volltextzugriff (PDF)

Anti-MUC1 Monoclonal Antibody

PloS one, 2011-09, Vol.6 (9), p.e24405

2011

Volltextzugriff (PDF)

1 – 25 von 236

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(216)
Mit Volltextzugriff
(228)

Publikationsform

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(182)
Life Sciences & Biomedicine
(97)
Physical Sciences
(64)
Chemistry
(44)
Technology
(43)
Humans
(35)
Animals
(26)
Engineering
(21)
Materials Science
(21)
Male
(20)
Biochemistry & Molecular Biology
(18)
Oncology
(18)
Materials Science, Multidisciplinary
(17)
Mice
(17)
Science & Technology - Other Topics
(17)
Chemistry, Multidisciplinary
(15)
Female
(14)
Proteins
(14)
Apoptosis
(13)
Gene Expression
(13)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Cancer stem cells and signaling pathways in radioresistance

Emerging roles of radioresistance in prostate cancer metastasis and radiation therapy

Cancer stem cells in prostate cancer chemoresistance

Proteomics discovery of radioresistant cancer biomarkers for radiotherapy

Anti-MUC1 monoclonal antibody (C595) and docetaxel markedly reduce tumor burden and ascites, and prolong survival in an in vivo ovarian cancer model

In vitro and in vivo prostate cancer metastasis and chemoresistance can be modulated by expression of either CD44 or CD147

Proteomic identification of the lactate dehydrogenase A in a radioresistant prostate cancer xenograft mouse model for improving radiotherapy

Combination therapy with the histone deacetylase inhibitor LBH589 and radiation is an effective regimen for prostate cancer cells

Low dose histone deacetylase inhibitor, LBH589, potentiates anticancer effect of docetaxel in epithelial ovarian cancer via PI3K/Akt pathway in vitro

Monitoring Prostate Tumor Growth in an Orthotopic Mouse Model Using Three-Dimensional Ultrasound Imaging Technique

Targeting PI3K/Akt/mTOR signaling pathway in the treatment of prostate cancer radioresistance

Epithelial cell adhesion molecule (EpCAM) is associated with prostate cancer metastasis and chemo/radioresistance via the PI3K/Akt/mTOR signaling pathway

TEM study on the microstructure of the Zn-Al-Mg alloy

Identification of protein biomarkers and signaling pathways associated with prostate cancer radioresistance using label-free LC-MS/MS proteomic approach

Co-expression of CD147/EMMPRIN with monocarboxylate transporters and multiple drug resistance proteins is associated with epithelial ovarian cancer progression

Applicability of Artificial Recharge of Groundwater in the Yongding River Alluvial Fan in Beijing through Numerical Simulation

Abstract 2001: Identification of lactate dehydrogenase A (LDHA) as a potential therapeutic target for prostate cancer radiotherapy

Abstract A283: PI3K/Akt/mTOR dual inhibitors have an advantage over single inhibitors in overcoming prostate cancer radioresistance

CD44 is a biomarker associated with human prostate cancer radiation sensitivity

Abstract 4005: CD44 isoform variant 6 is associated with prostate cancer progression, metastasis and chemo-/radio-resistance via PI3K/Akt/mTOR and Wnt/β-catenin signaling pathways in vitro

Low dose histone deacetylase inhibitor, LBH589, potentiates anticancer effect of docetaxel in epithelial ovarian cancer via PI3K/Akt pathwayin vitro

Kvl.3 channel blockade enhances the phagocytic function of RAW264.7 macrophages

Monoclonal antibody targeting MUC1 and increasing sensitivity to docetaxel as a novel strategy in treating human epithelial ovarian cancer

Monitoring Prostate Tumor Growth in an Orthotopic Mouse Model Using Three-Dimensional Ultrasound Imaging Technique12

Anti-MUC1 Monoclonal Antibody

Suchergebnisse filtern